COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.
As of February 23, 2023, Taiwan's Central Epidemic Command Center (CECC) said that 94% of the population had received at least one dose of COVID-19 vaccine, 76.3% had had a booster shot, and 23% had received a third dose.
As of 21 October 2022, 21,761,873 people, or 93.81% of the Taiwanese population has received at least one dose, while 20,447,829 people, or 88.14% of the population have received at least two doses, while 17,102,993, or 73.73% of the population have received at least three, while 3,300,926 people, or 14.23% of the population having received at least four, and 249,559 people, or 1.1% of the population, having received all five. A further 185,463 immunocompromised individuals, or 0.8% of the population, have received a weakened version of the booster dose. 93.96% of those over 12 have received the first booster dose, while 41.4% of those over 65 have received the second booster dose.
Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.
Timeline
2021
March to May
On 3 March 2021 the first shipment of the Oxford–AstraZeneca COVID-19 vaccine was delivered. The 117,000 doses are part of the 10 million doses of the vaccine that the Taiwanese government had previously ordered.
On 18 March the AstraZeneca vaccine was approved by the government, and vaccinations commenced on 22 March 2021. The vaccine is free for all Taiwanese people and long-term residents. Health workers, other frontline workers and seniors were the first to be inoculated with the vaccine.
On 5 May the Moderna COVID-19 vaccine was approved for emergency use, and the first batch of 150,000 doses was delivered on 28 May 2021.
On 17 May 400,000 doses of the AstraZeneca vaccine that were ordered through COVAX arrived in the midst of Taiwan's largest COVID-19 pandemic.
On 31 May Taiwan Centers for Disease Control announced that 10 million doses of domestically produced vaccines (Medigen and United Biomedical) had been pre-reserved. 5 million of each vaccine were reserved. They are expected to be approved and deployed sometime in July 2021.
June
On 2 June Taiwan recorded the first case of blood clotting linked to the Oxford–AstraZeneca COVID-19 vaccination.
On 4 June Japan donated 1.24 million doses of the Oxford–AstraZeneca COVID-19 vaccine to Taiwan.
On 6 June three American senators who arrived in Taiwan announced that the United States will donate 750,000 vaccine doses to Taiwan, the brand of which is still currently unknown. On 20 June 2.5 million Moderna vaccine doses arrived, which represented an increase from the 750,000 doses pledged. The doses arrived on a China Airlines flight from Memphis.
On 18 June Taiwan Centers for Disease Control announced that a second shipment of 240,000 doses of the Moderna vaccine were set to arrive in Taiwan from Luxembourg.
On 22 June the government of Lithuania announced that it was donating 20,000 doses of AstraZeneca vaccine in September. It was announced that earlier in the pandemic, Taiwan had sent 100,000 masks to Lithuania in a time of need.
July
On 4 July the Taiwanese government has successfully vaccinated 10% of the population with at least one dose of COVID-19 vaccine.
On 7 July the first batch of a Thailand-made AstraZeneca vaccine arrived in Taiwan. The 625,000 doses are part of the 10 million doses that the Taiwanese government had previously ordered.
On 8 July Japan donated another 1.13 million doses of the AstraZeneca vaccine to Taiwan. Combined with the first donation, Japan has donated a total of 2.37 million doses of the vaccine to Taiwan.